EMD-16441

Single-particle
3.7 Å
EMD-16441 Deposition: 10/01/2023
Map released: 24/01/2024
Last modified: 09/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16441

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8c5r summary report (pdf.gz) Map-8c5r FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Omicron B.1.1.529 2 RBD up conformation

EMD-16441

Single-particle
3.7 Å
EMD-16441 Deposition: 10/01/2023
Map released: 24/01/2024
Last modified: 09/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Alphacoronavirus
Sample: Omicron Spike trimeric complex
Fitted models: 8c5r

Deposition Authors: Raghavan SSR , Walker MR , Salanti A , Barfod LK, Wang KT
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.
PUBMED: 39354108
DOI: doi:10.1038/s42003-024-06951-7
ISSN: 2399-3642